Evidence map›Paper›PMID 33282769›Full record

ArticleJournal of International Society of Preventive & Community Dentistry

The Knowledge and Perception of Antiplatelet and Anticoagulant agents among Dentists in Northern Jordan.

Rasheed K Ibdah, Sukaina I Rawashdeh, Ehab Harahsheh, Abdallah Almegdadi, Abdullah Al Ksassbeh, Nasr Alrabadi

Open access · greenAbstract read
In one paragraph

Article in Journal of International Society of Preventive & Community Dentistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Rasheed K IbdahDivision of Cardiology, Department of Internal Medicine, Jordan University for Science and Technology, Irbid, Jordan.
Sukaina I RawashdehDivision of Cardiology, Department of Internal Medicine, Jordan University for Science and Technology, Irbid, Jordan.
Ehab HarahshehDepartment of Neurology, Mayo Clinic College of Medicine, Arizona, USA.
Abdallah AlmegdadiDivision of Cardiology, Department of Internal Medicine, Jordan University for Science and Technology, Irbid, Jordan.
Abdullah Al KsassbehDivision of Cardiology, Department of Internal Medicine, Jordan University for Science and Technology, Irbid, Jordan.
Nasr AlrabadiDepartment of Pharmacology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Jordan University of Science and Technology · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of this study was to describe the attitude and perception toward antiplatelet/anticoagulant agents in patients with cardiovascular diseases among dentists in the northern district of Jordan and to compare the current practice of Jordanian dentists and the recently published guidelines regarding the management of patients taking antiplatelet/anticoagulant drugs before dental procedures. MATERIALS AND

methodsThis is a cross-sectional study conducted on dentists and dental interns working at the dental clinics in northern Jordan, including dental clinics at Jordan University of Science and Technology (JUST) and the private sector. The total sample size comprised of 128 subjects (78 dentists from JUST and 50 private practitioners). The participants were interviewed using a preformed questionnaire to assess their knowledge and perceptions regarding the antiplatelets and the anticoagulant agents.

resultsApproximately 61.5% of participants from JUST university and 20.0% of those in the private sector were aware of the use of clopidogrel (

conclusionsThe awareness regarding the newest antiplatelet/anticoagulant agents is poor among the dentists in northern Jordan. However, the majority (62.3%) of them realize the consequences of interrupting such treatments in patients with coronary stents. Unfortunately, only a quarter of the dentists are consulting the cardiologists before interrupting the treatment with the antiplatelet agents. Proper education, courses, and workshops should be performed to the dentists to improve their knowledge about this critical issue.

Indexed as

Anticoagulantsantiplateletscoronary stentsdental proceduresischemic heart disease

Identifiers

PMID33282769
PMCPMC7685271
OpenAlexW3091037835

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.